tradingkey.logo

Helix Acquisition Corp II

HLXB

9.060USD

-1.374-13.17%
Horarios del mercado ETCotizaciones retrasadas 15 min
212.99MCap. mercado
44.57P/E TTM

Helix Acquisition Corp II

9.060

-1.374-13.17%
Más Datos de Helix Acquisition Corp II Compañía
Helix Acquisition Corp. II is a blank check company. The Company is formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses, which it refers to as its initial business combination. The Company has not selected any specific business combination target and it has not, nor has anyone on its behalf, engaged in any substantive discussions, directly or indirectly, with any business combination. While it may pursue a business combination target in any business or industry, it intends to focus on healthcare or healthcare related industries. The Company has not generated any revenue.
Información de la empresa
Símbolo de cotizaciónHLXB
Nombre de la empresaHelix Acquisition Corp II
Fecha de salida a bolsaFeb 09, 2024
Director ejecutivoMs. Bihua Chen
Número de empleados- -
Tipo de seguridadOrdinary Share
Fin del año fiscalFeb 09
DirecciónC/O Cormorant Asset Management, Lp
CiudadBOSTON
Bolsa de valoresNASDAQ Global Market Consolidated
PaísUnited States of America
Código postal02116
Teléfono18577020377
Sitio Web
Símbolo de cotizaciónHLXB
Fecha de salida a bolsaFeb 09, 2024
Director ejecutivoMs. Bihua Chen
Ejecutivos de la empresa
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. Albert A. Holman, III
Mr. Albert A. Holman, III
Independent Director
Independent Director
--
--
Mr. Mark C. Mckenna
Mr. Mark C. Mckenna
Independent Director
Independent Director
--
--
Mr. John P. Schmid
Mr. John P. Schmid
Independent Director
Independent Director
--
--
Ms. Bihua Chen
Ms. Bihua Chen
Chairman of the Board, Chief Executive Officer
Chairman of the Board, Chief Executive Officer
--
--
Mr. Caleb Tripp
Mr. Caleb Tripp
Chief Financial Officer
Chief Financial Officer
--
--
Mr. Nebojsa Obradovic
Mr. Nebojsa Obradovic
Chief Legal Officer
Chief Legal Officer
--
--
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. Albert A. Holman, III
Mr. Albert A. Holman, III
Independent Director
Independent Director
--
--
Mr. Mark C. Mckenna
Mr. Mark C. Mckenna
Independent Director
Independent Director
--
--
Mr. John P. Schmid
Mr. John P. Schmid
Independent Director
Independent Director
--
--
Ms. Bihua Chen
Ms. Bihua Chen
Chairman of the Board, Chief Executive Officer
Chairman of the Board, Chief Executive Officer
--
--
Mr. Caleb Tripp
Mr. Caleb Tripp
Chief Financial Officer
Chief Financial Officer
--
--
Mr. Nebojsa Obradovic
Mr. Nebojsa Obradovic
Chief Legal Officer
Chief Legal Officer
--
--
Desglose de ingresos
Sin datos
Sin datos
Por negocio
Por región
Sin datos
Estadísticas de accionistas
Actualizado: sáb., 12 de jul
Actualizado: sáb., 12 de jul
Accionistas
Tipos de accionistas
Accionistas
Accionistas
Proporción
Chen (Bihua X.)
39.08%
Cormorant Asset Management, LP
15.38%
BlackRock Financial Management, Inc.
7.70%
Citadel Advisors LLC
7.47%
Adage Capital Management, L.P.
7.40%
Other
22.96%
Accionistas
Accionistas
Proporción
Chen (Bihua X.)
39.08%
Cormorant Asset Management, LP
15.38%
BlackRock Financial Management, Inc.
7.70%
Citadel Advisors LLC
7.47%
Adage Capital Management, L.P.
7.40%
Other
22.96%
Tipos de accionistas
Accionistas
Proporción
Hedge Fund
63.40%
Individual Investor
39.08%
Investment Advisor/Hedge Fund
10.95%
Investment Advisor
10.09%
Corporation
5.82%
Private Equity
2.10%
Research Firm
1.53%
Participación institucional
Actualizado: mar., 1 de jul
Actualizado: mar., 1 de jul
Periodo del informe
Número de instituciones
Acciones mantenidas
Proporción
Cambio
2025Q2
44
24.98M
132.09%
+8.22M
2025Q1
44
17.89M
94.60%
+829.91K
2024Q4
41
17.82M
94.24%
+1.30M
2024Q3
37
17.47M
92.41%
+1.09M
2024Q2
35
17.48M
94.85%
+1.41M
2024Q1
33
17.17M
90.80%
+8.90M
Actividad de los accionistas
Nombre
Acciones mantenidas
Proporción
Cambio
Cambio %
Fecha
Cormorant Asset Management, LP
2.91M
15.38%
--
--
Jun 18, 2025
BlackRock Financial Management, Inc.
1.46M
7.7%
--
--
Mar 31, 2025
Citadel Advisors LLC
1.41M
7.47%
+72.29K
+5.40%
Mar 31, 2025
Adage Capital Management, L.P.
1.40M
7.4%
--
--
Mar 31, 2025
BC Global Opportunities IX LP
1.10M
5.82%
+1.10M
--
Feb 09, 2024
T. Rowe Price Associates, Inc.
1.07M
5.67%
-16.22K
-1.49%
Mar 31, 2025
Sculptor Capital Management, Inc
800.00K
4.23%
+95.00K
+13.48%
Mar 31, 2025
Millennium Management LLC
1.10M
5.8%
-45.92K
-4.02%
Mar 31, 2025
SilverArc Capital Management, LLC
613.39K
3.24%
+100.02K
+19.48%
Mar 31, 2025
Ver más
ETFs relacionados
Actualizado: sáb., 2 de ago
Actualizado: sáb., 2 de ago
Nombre
Proporción
iShares Health Innovation Active ETF
0%
iShares Health Innovation Active ETF
Proporción0%
Dividendos
Un total de 0.00 USD se ha distribuido en dividendos durante los últimos 5 años.
Fecha
Dividendos
Fecha de registro
Fecha de pago
Fecha ex-dividendo
Sin datos
División de acciones
Fecha
Tipo
Relación
Sin datos
Fecha
Tipo
Relación
Sin datos
KeyAI